Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00299416 · ClinicalTrials.gov registry record · Phase 1
Caffeinol Hypothermia Protocol
A Phase 1 study of Acute Ischemic Stroke, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00299416 is a Phase 1 study of Acute Ischemic Stroke that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 30 participants, below the 351-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00299416, a Phase 1 study of Acute Ischemic Stroke, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Caffeinol is a combination of caffeine and alcohol. The amount given is about the same as 1-2 glasses of wine and 3-4 cups of coffee. The patient receives a one time dose given over two hour while being cooled to 34.5 C.
Conditions Studied
Interventions
- DRUG Caffeinol
- PROCEDURE hypothermia
Study Locations (1)
Texas
- Memorial Hermann Hospital - Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00299416
The ClinicalTrials.gov registry entry for NCT00299416 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 351-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (91% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Caffeinol is the first listed.
NCT00299416 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00299416 about?
NCT00299416 is a clinical study titled "Caffeinol Hypothermia Protocol". Caffeinol is a combination of caffeine and alcohol. The amount given is about the same as 1-2 glasses of wine and 3-4 cups of coffee. The patient receives a one time dose given over two hour while being cooled to 34.5 C.
What is the current status of trial NCT00299416?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2003-02. Estimated completion is 2009-08.
What conditions does trial NCT00299416 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke.
What interventions are being tested in trial NCT00299416?
The interventions under investigation include: Caffeinol (DRUG), hypothermia (PROCEDURE).
Who is sponsoring clinical trial NCT00299416?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00299416 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
COMPLETED · Phase 1
-
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
RECRUITING · Phase 2
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
RECRUITING · Phase 3
-
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
RECRUITING · Phase 2
-
SUMMIT RISE Study of Acute Ischemic Stroke Patients
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.